Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25511514)

Published in Anticancer Agents Med Chem on January 01, 2015

Authors

Richard T Arkwright, Rahul Deshmukh, Nikhil Adapa, Ryan Stevens, Emily Zonder, Zhongyu Zhang, Pershang Farshi, Reda Saber Ibrahim Ahmed, Hossny Awad El-Banna, Tak-Hang Chan, Q Ping Dou1

Author Affiliations

1: Barbara Ann Karmanos Cancer Institute and Department of Oncology, School of Medicine, Wayne State University, 540.1 HWCRC, 4100 John R Road, Detroit, MI 48201- 2013. doup@karmanos.org.

Articles by these authors

Oxidation of heme to beta- and delta-biliverdin by Pseudomonas aeruginosa heme oxygenase as a consequence of an unusual seating of the heme. J Am Chem Soc (2002) 1.98

Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol (2012) 1.70

Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design. Proteins (2004) 1.26

Periacetabular osteotomy: preoperative radiographic predictors of outcome. Clin Orthop Relat Res (2002) 1.25

Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol Med (2002) 1.22

Crystal structures of the NO- and CO-bound heme oxygenase from Neisseriae meningitidis. Implications for O2 activation. J Biol Chem (2003) 1.09

The hydroxide complex of Pseudomonas aeruginosa heme oxygenase as a model of the low-spin iron(III) hydroperoxide intermediate in heme catabolism: 13C NMR spectroscopic studies suggest the active participation of the heme in macrocycle hydroxylation. J Am Chem Soc (2003) 1.04

From bortezomib to other inhibitors of the proteasome and beyond. Curr Pharm Des (2013) 1.04

Sonic hedgehog shedding results in functional activation of the solubilized protein. Dev Cell (2011) 1.02

Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr Cancer (2008) 1.00

Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors. Anticancer Res (2004) 1.00

Regioselective Acylation of Hexopyranosides with Pivaloyl Chloride. J Org Chem (1998) 0.99

A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev Res (Phila) (2011) 0.97

Mixed regioselectivity in the Arg-177 mutants of Corynebacterium diphtheriae heme oxygenase as a consequence of in-plane heme disorder. Biochemistry (2004) 0.95

A comparison of leaf and petal senescence in wallflower reveals common and distinct patterns of gene expression and physiology. Plant Physiol (2008) 0.93

Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants. Drug Metab Dispos (2008) 0.89

Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. BMC Cancer (2011) 0.88

Development of extracellular signal-regulated kinase inhibitors. Curr Top Med Chem (2009) 0.84

Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening. J Chem Inf Model (2013) 0.84

Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit. Int J Mol Med (2006) 0.84

An emerging role of Sonic hedgehog shedding as a modulator of heparan sulfate interactions. J Biol Chem (2012) 0.84

Therapeutic potential of GABA(B) receptor ligands in drug addiction, anxiety, depression and other CNS disorders. Pharmacol Biochem Behav (2013) 0.82

Aerobic and electrochemical oxidative cross-dehydrogenative-coupling (CDC) reaction in an imidazolium-based ionic liquid. Chemistry (2010) 0.81

Attenuating effect of standardized lyophilized Cinnamomum zeylanicum bark extract against streptozotocin-induced experimental dementia of Alzheimer's type. J Basic Clin Physiol Pharmacol (2015) 0.81

A novel rabbit model for studying RPE transplantation. Invest Ophthalmol Vis Sci (2008) 0.80

Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats. Eur J Pharmacol (2013) 0.79

A novel approach to oligonucleotide synthesis using an imidazolium ion tag as a soluble support. J Org Chem (2006) 0.79

SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav (2010) 0.79

Combined silicone oil removal with secondary implantation of anterior chamber or sclera-fixed posterior chamber intraocular lenses. Eur J Ophthalmol (2013) 0.78

Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders. Eur J Pharmacol (2013) 0.78

Throwing injuries: diagnosis and treatment. Arthroscopy (2003) 0.78

Ionic-liquid-supported peptide synthesis demonstrated by the synthesis of Leu(5)-enkephalin. J Org Chem (2005) 0.78

The inhibitory effects and mechanisms of rhamnogalacturonan I pectin from potato on HT-29 colon cancer cell proliferation and cell cycle progression. Int J Food Sci Nutr (2012) 0.77

Anti-hyperalgesic and anti-nociceptive potentials of standardized grape seed proanthocyanidin extract against CCI-induced neuropathic pain in rats. J Basic Clin Physiol Pharmacol (2016) 0.77

Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.77

Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present). Expert Opin Ther Pat (2012) 0.76

Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav (2012) 0.76

Effect of licofelone--a dual COX/5-LOX inhibitor in intracerebroventricular streptozotocin-induced behavioral and biochemical abnormalities in rats. J Mol Neurosci (2014) 0.76

Antitumor activity of bee pollen polysaccharides from Rosa rugosa. Mol Med Rep (2013) 0.76

Validation of the AmpC β-lactamase binding site and identification of inhibitors with novel scaffolds. J Chem Inf Model (2012) 0.76

Vascular adhesion protein 1 in the eye. J Ophthalmol (2013) 0.75

The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis. J Cell Mol Med (2014) 0.75

In vivo molecular imaging in retinal disease. J Ophthalmol (2012) 0.75

A dog is not a rat: importance of understanding species differences in drug absorption, distribution, metabolism and excretion (ADME). Vet J (2009) 0.75

2-Amino-5-methyl-pyridinium nitrate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75

Ameliorating effect of lyophilized extract of Butea frondosa leaves on scopolamine-induced amnesia in rats. Pharm Biol (2012) 0.75

L-Ornithine Schiff base-copper and -cadmium complexes as new proteasome inhibitors and apoptosis inducers in human cancer cells. J Biol Inorg Chem (2014) 0.75

Collision-induced dissociation of sulfur-containing imidazolium ionic liquids. J Mass Spectrom (2008) 0.75

Oligonucleotide synthesis using ionic liquids as soluble supports. Nucleosides Nucleotides Nucleic Acids (2007) 0.75

Anti-human milk fat globulin staining of perifollicular xanthomatosis in Fox-Fordyce disease. J Cutan Pathol (2012) 0.75

NMR assignments of cd-HO, a 24 kDa heme oxygenase from Corynebacterium diphtheria. Biomol NMR Assign (2007) 0.75

Hydrophilic polymer microemboli in a patient with a chronic cutaneous ulcer: a case report. J Cutan Pathol (2014) 0.75

Coherent perfect absorption mediated anomalous reflection and refraction. Opt Lett (2012) 0.75

Skin cancer prevention in annual performance of total skin examination, photoprotection counseling, and patient instruction of self-skin examination. Int J Dermatol (2013) 0.75